January 2005- Volume 1, Issue 1
In this Issue
Informatics
Amgen Ventures to fund emerging biotech companies
Amgen Ventures to fund emerging biotech companies
With $100 million in its coffers, Amgen Ventures, a corporate venture capital fund initiated by Amgen Inc. in late 2004, will provide monetary assistance for emerging biotechnology companies that work in Amgen’s areas of interest related to human therapeu
Nonlinear Dynamics, GenoLogics team up
Nonlinear Dynamics, GenoLogics team up
After several months of discussions, GenoLogics Life Sciences Software Inc., based here, and Nonlinear Dynamics of Newcastle upon Tyne, England, have entered into a global partnership agreement that will result in an integrated protein informatics softwar
News Briefs
News Briefs
Bioinformatics News Briefs
Tripos acquires Optive Research
Tripos acquires Optive Research
In a move that further broadens its offerings in bioinformatics software, Tripos Inc. closed its acquisition earlier this month for Austin, Texas-based Optive Research, a two-year old technology and software spinout of the University of Texas at Austin.
Accelerator adds venture partners
Accelerator adds venture partners
Funding boosts capital pool by $11.8 million and adds informatics expertise
Research & Development
California Dreamin’: Proposition 71 puts stem cell research on fast track
California Dreamin’: Proposition 71 puts stem cell research on fast track
Somewhat lost among the rising cheers of public and private research institutions after the passage of California Proposition 71, a measure that will provide nearly $3 billion in public funding in the state for stem cell research over the next 10 years, w
Novasite gets NIH grant
Novasite gets NIH grant
Novasite Pharmaceuticals Inc. announced it has received a four-year grant valued at nearly $3.4 million for continued development of its proprietary parallel screening technology for G-Protein Coupled Receptors (GPCRs).
News Briefs
News Briefs
Research Technology News Briefs
Ricerca Biosciences expands
Ricerca Biosciences expands
Ricerca Biosciences LLC in December completed a capacity expansion of its in vivo pre-clinical testing capability and was also in the process of a similar expansion in its medicinal chemistry and chemical development services. The additional capacity was
Plexxikon bolsters R&D
Plexxikon bolsters R&D
Success of company’s Scaffold-Based Drug Discovery platform puts it on development fast track
Genomics & Proteomics
Invitrogen launches Human ProtoArray
Invitrogen launches Human ProtoArray
With more than 1,800 proteins on its surface, the new product marks the debut of high-density protein microarrays
Applied Bio names CSO
Applied Bio names CSO
Chief Scientific Officer leads convergence of technology, science
NIST tackles gene expression QC
NIST tackles gene expression QC
With the recent launch of the multidisciplinary Metrology for Gene Expression Program, the National Institute of Standards and Technology (NIST) is hoping to explore and address the challenges associated with the measurement, validation, and quality contr
Ciphergen sells BioSepra to Pall
Ciphergen sells BioSepra to Pall
Pall Corp. in late 2004 finalized the $32-million purchase of Ciphergen Biosystems Inc.’s process chromatography sorbent business. The acquisition of the BioSepra Process Division fills a crucial “missing link” in Pall’s extensive fluid management offerin
Geron in license deal with Cambrex for distribution of telomeraze-immortalized human cell lines
Geron in license deal with Cambrex for distribution of telomeraze-immortalized human cell lines
Geron Corp. in January announced a worldwide license agreement with Cambrex Bio Science Walkersville Inc. under which the Cambrex subsidiary will develop and distribute cell lines that have been immortalized using Geron’s proprietary telomerase technology
News Briefs
News Briefs
Genomics & Proteomics News Briefs
Global News
Pellini named BioAdvance Entrepreneur-in-Residence
Pellini named BioAdvance Entrepreneur-in-Residence
The Biotechnology Greenhouse of Southeastern Pennsylvania BioAdvance recently announced the selection of Dr. Michael Pellini as the organization’s inaugural Entrepreneur-in-Residence. Part of a $2-billion initiative by the Commonwealth of Pennsylvania to
ViroLogic and ACLARA merge
ViroLogic and ACLARA merge
Company sees ‘explosive’ potential in targeted therapeutics
Agilent Technologies expands genomic microarray platform
Agilent Technologies expands genomic microarray platform
Acquisition of Computational Biology provides key ChIP-on-Chip technology
Sign o’ the times? Drug discovery companies ramp up investments in China
Sign o’ the times? Drug discovery companies ramp up investments in China
Within a single week, two major players in the drug discovery instrumentation and reagent industry—Thermo Electron and Invitrogen—made moves to capitalize on the ever-strengthening Chinese biotechnology and pharmaceutical markets, further entrenching the
Thermo intros LeadStream
Thermo intros LeadStream
Integrated ADMETox platform aimed at easing preclinical bottleneck and lowering development attrition rates.
Automation & Instrumentation
Caliper Life Sciences licenses microfluidics patents to Predicant
Caliper Life Sciences licenses microfluidics patents to Predicant
Predicant becomes the first company to gain technology rights as Caliper adopts a more expansive out-licensing strategy for its intellectual property estate
Lab-on-a-chip takes next step
Lab-on-a-chip takes next step
The lab-on-a-chip (LOC) field may be about to hit its stride with the recent introduction of a fully automated system by Agilent Technologies. Designed to replace gel electrophoresis steps, the Agilent 5100 ALP allows researchers to perform thousands of u
PerkinElmer, Procognia team up for high–throughput protein array
PerkinElmer, Procognia team up for high–throughput protein array
Health science heavyweight PerkinElmer and proteomics technology developer Procognia announced in mid-December a co-marketing agreement that combines PE’s Protein Array Workstation and ProScan Array HT with Procognia’s U-c lectin array-based platform to c
Optics specialist Bookham focuses on life sciences
Optics specialist Bookham focuses on life sciences
In late 2004, Bookham New Focus introduced the Clarity line of fluorescence filters, developed for use in analytical and diagnostic instruments, including fluorescence microscopy, flow cytometry, DNA sequencing, microarrays, and other fluorescence applica
News Briefs
News Briefs
Automation & Instrumentation News Briefs
